Please Wait...

Jeremy Daniel

Main profile

Senior Product Developer

Jeremy Daniel is a Senior Product Developer for BioClinica Optimizer. Jeremy has worked with Optimizer for the past four years. He has supported major pharmaceutical companies to analyze many large trials and to develop new features in Optimizer to better support complex trial designs. Jeremy also did some early work on Trident and its interface to Optimizer. He has a BS Computer Science from MIT and has worked for over 10 years on various technology projects supporting clinical research.

Blogs

We often run into cases where an IVR (interactive voice response) system may not generate shipment orders for study kits every day. For example, commonly it seems they may only ship Monday through Thursday. In many cases this could be due to cold chain supplies having to be received immediately and being unable to guarantee that someone will be there to receive the shipment on a weekend. Others, however, may be for unrelated policy reasons. Standard modeling practice says to add a day to the shipping lead-time for every day that is not available for shipping (3 days in the case of the above example). Related to this concept, there is often some confusion for new users about whether the shipping lead-time for the IVR study refers to calendar days or business days.

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Bioclinica is organized into three business segments so that we can provide expert service and multifaceted technologies. Our Medical Imaging & Biomarkers segment includes an Imaging Core Lab, a Cardiovascular Safety division, and a Molecular Marker Laboratory. Our eHealth segment comprises eClinical Solutions, Randomization & Trial Supply Management, Safety & Regulatory Solutions, and Financial Lifecycle Solutions. Under the Global Clinical Research segment, we offer a network of research sites, patient recruitment, and a Post-Approval Research division.

What's next from Bioclinica? Hear if first during #PCTrials Europe next week in Amsterdam! https://t.co/ICngaxA9mg https://t.co/SXxPj3NpD2
bioclinica (5 hours ago)
Join Bioclinica's Justin Hunt on Nov. 28 in a live webinar! Find out how to overcome common hurdles in CTMS impleme… https://t.co/wHfWHtI7sj
bioclinica (Yesterday)
Another CRO seeing big gains in the sites payments process! Access the Case Study here https://t.co/jsCxhmKcLo https://t.co/LpIKEtBKtE
bioclinica (Yesterday)
Great advice from our Dir. Cardiovascular Imaging on quality imaging acquisitions & assessments in clin trials. https://t.co/OVH7pZ3SL0
bioclinica (Yesterday)
Almost here! #PCTrials Pre-arrange a meeting w @bioclinica Drop by & s/w David Kiger & Mike Lange. Mike will give a… https://t.co/8ymd2Q9KcJ
bioclinica (Yesterday)
Almost here! #PCTrials Pre-arrange a meeting w @bioclinica Drop by & s/w David Kiger & Mike Lange. Mike will giv… https://t.co/MpxTDV1T1L
bioclinica (Yesterday)

Latest Blogs:

Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen
Congressman Meehan and Bioclinica CEO John Hubbard at recent visit to Bioclinica's Audubon offices